Literature DB >> 31186872

Drugs used in therapy of portal hypertension.

Dhiraj Tripathi1.   

Abstract

Entities:  

Year:  2012        PMID： 31186872      PMCID： PMC6499293          DOI： 10.1002/cld.97

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  13 in total

Review 1.  Review article: a drug therapy for the prevention of variceal haemorrhage.

Authors:  D Tripathi; P C Hayes
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

2.  Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'.

Authors:  D E Newby; P C Hayes
Journal:  QJM       Date:  2002-12

3.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2010-06-27       Impact factor: 25.083

4.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Arun J Sanyal; Norman D Grace; William Carey
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

Review 5.  Pregnancy and cirrhosis.

Authors:  Jennifer Tan; Bijal Surti; Sammy Saab
Journal:  Liver Transpl       Date:  2008-08       Impact factor: 5.799

6.  Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.

Authors:  Thomas Sersté; Christian Melot; Claire Francoz; François Durand; Pierre-Emmanuel Rautou; Dominique Valla; Richard Moreau; Didier Lebrec
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

7.  Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.

Authors:  Soon Koo Baik; Phil Ho Jeong; Sang Won Ji; Byung Su Yoo; Hyun Soo Kim; Dong Ki Lee; Sang Ok Kwon; Young Ju Kim; Joong Wha Park; Sei Jin Chang; Samuel S Lee
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

8.  Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.

Authors:  Dhiraj Tripathi; James W Ferguson; Narendra Kochar; Joanna A Leithead; George Therapondos; Norma C McAvoy; Adrian J Stanley; Ewan H Forrest; William S Hislop; Peter R Mills; Peter C Hayes
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

Review 9.  The role of carvedilol in the management of portal hypertension.

Authors:  Dhiraj Tripathi; Peter C Hayes
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-08       Impact factor: 2.566

10.  Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.

Authors:  J C García-Pagán; C Villanueva; A Albillos; R Bañares; R Morillas; J G Abraldes; J Bosch
Journal:  Gut       Date:  2009-02-12       Impact factor: 23.059
View more
  2 in total

Review 1.  Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension.

Authors:  Wolfgang Kreisel; Denise Schaffner; Adhara Lazaro; Jonel Trebicka; Irmgard Merfort; Annette Schmitt-Graeff; Peter Deibert
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

2.  Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation.

Authors:  He-Yun Cheng; Hsiu C Lin; Hsiu L Lin; Yow S Uang; Joseph J Keller; Li H Wang
Journal:  Front Pharmacol       Date:  2022-01-07       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.